IBIO (iBio Inc) Sof foyda

IBIO (iBio) - kompaniyaning tovar belgisi

Boshqaruvi biznesni AI asosidagi antitanalar ishlab chiqishga yo'naltirayotgan iBio, Inc. (IBIO) kompaniyasiga investitsiya kiritishga arziydimi? GURU.Markets platformasida kompaniyaning yillik moliyaviy natijalari javobni beradi, u yerda -0.03 qiymati ushbu holatni aks ettiradi. Brendning onkologiya sohasidagi yuqori nufuzi aniq muhandislikning to'g'riligiga asoslangan; biroq, tijorat mahsulotlarining yo'qligi uning moliyaviy holatini tashqi grantlar va investitsiyalarga bog'liq qilib qo'ygan.

IBIO (iBio, Inc.) Sof foyda tarixi 04.07.2022dan 29.10.2026gacha

iBio (IBIO) kompaniyasining tahliliy kesimlari va maʼlumotlar hisoboti

- narx va narxlar bo'yicha konsensus prognoz:
Aksiya kotirovkalari iBio Corporation|IBIO - Tahlilchilar konsensus prognozi
- biznesning bozor baholash ko'rsatkichlari:
Bozor kapitallashuvi iBio Corporation|IBIO - Kompaniyani butunlay sotib olishdagi haqiqiy narx
- balans kapitallashuvi bo'yicha ma'lumotlar:
Aksiyaning buxgalteriya qiymati iBio|IBIO - Balans kapitallashuvi|Balans qiymatiga nisbatan bozor kapitallashuvi ibioinc.com|IBIO - Kompaniyaning jami aktivlari
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning xususiy kapitalga nisbati iBio, Inc.|IBIO - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati iBio Inc|IBIO - Kompaniyaning umumiy qarzi|Balans kapitallashuviga qarzlar iBio Corporation|IBIO - Kompaniyaning uzoq muddatli qarzi|Kompaniyaning qisqa muddatli qarzdorligi iBio|Shoshilinch likvidlik ibioinc.com
- sof daromad va qiymat multiplikatorlari ko'rsatkichlari:
IBIO - Sof foyda
Kompaniyaning jamlanma tahlili:iBio, Inc.
iBio Corp asosiy tovari

Ushbu ko'rsatkich operatsion daromadning aksiyadorlik qiymatini ob'ektiv ravishda o'lchaydi va fundamental baholash uchun choraklik hisobotlarni uzluksiz kunlik ma'lumotlar oqimiga birlashtiradi. iBio, Inc. (IBIO) kompaniyasining daromadlarini tahlil qilish orqali investor saraton terapiyasi antitelalari ishlab chiqishda AI platformasidan foydalanishdan olingan moliyaviy daromadni kuzatishi mumkin, bu esa biotexnologik hamkorliklarning monetizatsiyasini va aktivni mahalliy cho'qqilarda sotib olish risklarini baholash imkonini beradi.

Asosiy raqobatchilar

Sof daromad argenx BVBA|BNTX (BioNTech SE) - Sof foyda|Sof foyda Abivax Pharma|Sof daromad ADMA (ADMA Biologics, Inc.)|PTGX (Protagonist Therapeutics, Inc.) - Yakuniy foyda|Sof foyda IMVT (Immunovant Corp)|Sof moliyaviy natija Kiniksa Corp (KNSA)|GRFS - Kompaniyaning sof foydasi|adaptivebiotech.com (ADPT) - Sof daromad|Celldex Therapeutics, Inc. (CLDX) - Kompaniyaning sof foydasi|Sof daromad Aurinia Pharmaceuticals Inc|Sof daromad BCRX|Sof foyda Vera Corp|Kompaniyaning sof foydasi Dianthus Therapeutics (DNTH)|pharvaris.com - Kompaniya foydasi|Sof foyda ABCL (AbCellera Biologics Inc)|Tourmaline Bio Inc (TRML) - Kompaniyaning sof daromadi|Intrexon - Sof foyda|Sof moliyaviy natija Pharming Corp PHAR|NKTR: Sof foyda|UPB (upstreambio.com) - Kompaniyaning sof foydasi|ZBIO (Zenas Biopharma) - Sof foyda|Immunome Inc (IMNM) - Sof moliyaviy natija|Kompaniyaning sof foydasi Gossamer Corp (GOSS)|KALV - Kompaniyaning sof daromadi|Septerna Inc - Sof daromad|Yakuniy foyda PVLA|Savara - Sof foyda|Sof moliyaviy natija Rigel Pharma RIGL|AnaptysBio Corp (ANAB) - Kompaniyaning sof foydasi|Kompaniya foydasi ATXS|ENGN (enGene Holdings Inc.) - Sof foyda|Sof daromad rapt.com (RAPT)|Sof daromad JBIO (Aerovate Therapeutics Inc)|Sof moliyaviy natija Aclaris Therapeutics Inc.|Sof foyda KYTX (Kyverna)|Sof moliyaviy natija Tiziana Life Sciences, Ltd. (TLSA)|Cabaletta Bio, Inc. - Sof foyda|VTYX: Kompaniyaning sof foydasi|THTX: Sof foyda|AVTX - Sof moliyaviy natija|Kompaniyaning sof foydasi Eledon|Kompaniyaning sof daromadi Agenus, Inc AGEN|Kompaniyaning sof foydasi Climb Bio Inc (CLYM)|ZURA: Soliqdan keyingi foyda|Sof foyda ATYR (aTyr Pharma)|Yakuniy foyda ADAG|Ikena Oncology, Inc. - Sof foyda|STTK - Sof foyda|equilliumbio.com (EQ) - Kompaniyaning sof foydasi|Connect Biopharma Holdings Limited - Yakuniy foyda|Kompaniyaning sof foydasi Immunic Therapeutics|Sof daromad Atara Biotherapeutics Inc (ATRA)|Sof foyda IFRX|Sof foyda X4 Pharmaceuticals, Inc (XFOR)|Adicet Bio, Inc. - Sof daromad|Yakuniy foyda CELU|INmune Bio - Sof foyda|Sof moliyaviy natija Barinthus Biotherapeutics PLC BRNS|Kezar Life Sciences, Inc (KZR) - Kompaniyaning sof foydasi|Sof daromad SAB Biotherapeutics Inc|Kompaniyaning sof foydasi Akari Therapeutics|Sof daromad Enlivex Therapeutics, Ltd. (ENLV)|Sof daromad QTTB (Q32 Bio Inc.)|Sof foyda GeoVax Labs (GOVX)|Kompaniyaning sof foydasi Edesa EDSA|CARM: Kompaniya foydasi|XTL Biopharmaceuticals - Sof foyda|Kompaniyaning sof daromadi Bolt Biotherapeutics|HCWB: Sof foyda|APVO - Sof moliyaviy natija|AIM (AIM ImmunoTech) - Sof foyda|Kompaniyaning sof foydasi ADTX|Sof foyda GRI|Sof moliyaviy natija xortx.com|Kompaniyaning sof foydasi Vyome Holdings HIND|Revelation Biosciences Inc (REVB) - Kompaniyaning sof daromadi|INDP: Sof daromad|Yakuniy foyda SCNI (BiondVax Pharmaceuticals)|CALI: Sof foyda|AFMD - Sof moliyaviy natija|Kompaniyaning sof foydasi Allakos Inc|Kompaniya foydasi HOOK (HOOKIPA)|Sof foyda IGMS|Sof daromad iTeos Pharma ITOS|Ocean Biomedical, Inc. - Sof daromad|Sof moliyaviy natija tcbiopharm.com (TCBP)|Third Harmonic Bio, Inc. - Sof foyda